BioHealth News Archive
CarrTech Corp. Poised to Reduce Needle Sticks & Glass Shard Contamination in Medications
Revolutionizing the way healthcare providers administer medicines from glass ampoules FREDERICK, Md., Dec. 4, 2023 /PRNewswire-PRWeb/ -- CarrTech Corp., a woman-owned startup and Qualified Maryland Biotechnology…
Read More
Get Pre-Application Support through the NHLBI Innovator to Entrepreneur Program!
The National Heart Lung and Blood Institute (NHLBI) in partnership with the National Institute of Allergy and Infectious Diseases (NIAID) will be providing training…
Read More
Sara Nayeem, M.D., Experienced Biopharmaceutical Venture Investor, Joins Enavate Sciences as Executive Vice President, Investments
MENLO PARK, Calif., Dec. 4, 2023 /PRNewswire/ -- Enavate Sciences, a portfolio company of Patient Square Capital, is pleased to announce that Sara M. Nayeem, M.D. has joined the…
Read More
Baltimore’s MIRA Pharmaceuticals Releases Breakthrough Data from Artificial Intelligence Simulations
AI Simulation on MIRA1a Showcases Significant Potential Advantages Over Plant-Based Medical Marijuana Related to Anxiety, Appetite and Cognition BALTIMORE, Dec. 4, 2023 /PRNewswire/ -- MIRA Pharmaceuticals, Inc.…
Read More
ATCC Announces Award from NIAID to Consolidate its BEI Resources and NIH HIV Reagent Programs
The Biological and Emerging Infections Research Resources Program (BEI-RRP) contract, which merges the two programs, represents the fourth recompete award with NIAID since 2003.…
Read More
424 Capital Announces Investment in VaLogic
WAKEFIELD, Mass., Nov. 29, 2023 /PRNewswire/ -- 424 Capital announced today that it has completed a significant investment in VaLogic, a leading provider of GMP (Good…
Read More
citybiz Interviews Richard Hughen, CEO of Linshom Medical
Richard Hughen’s thirty years of professional medical device experience spans three Fortune 500 and four start-up companies with two successful exits to date. He…
Read More
MIMETAS and Yamaha Motor Sign Joint Marketing Agreement to Advance Automated Human Disease Model Applications for Drug Development
LEIDEN, the Netherlands, November 29, 2023 / B3C newswire / -- MIMETAS, a leader in human 3D disease modeling, and Yamaha Motor Co., Ltd., a…
Read More
REGENXBIO Announces Dose Escalation in AFFINITY DUCHENNE® Trial
ROCKVILLE, Md., Nov. 29, 2023 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that the first patient received RGX-202 at dose level 2 in the Phase I/II AFFINITY…
Read More
Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)
GAITHERSBURG, Md., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the Biomedical Advanced Research and Development Authority (BARDA) within the Administration for Strategic Preparedness…
Read More
Quroba Spotlights BHI Entrepreneur-in-Residence, Kwame Ulmer
BioHealth Innovation is thrilled to announce that our esteemed Entrepreneur-in-Residence, Kwame Ulmer, has been recognized by Quroba for his outstanding contributions to the MedTech…
Read More
TEDCO Invests in Baltimore Based NasaClip
COLUMBIA, Md. (November 27, 2023) – TEDCO, Maryland’s economic engine for technology companies, announced a recent $500,000 Social Impact Funds investment into NasaClip. “Nosebleeds…
Read More
End of Year 2023 Update: CarrTech Corp’s Notable Achievements and Future Endeavors
As the year 2023 comes to a close, CarrTech Corp has demonstrated remarkable progress and innovation in the biotechnology and medical device sectors. The…
Read More
cultivate(MD) Capital Funds LP Announces Investment into Previous BHCR Crab Trap Winner, Nanochon
GRAND RAPIDS, Mich., Nov. 27, 2023 /PRNewswire/ -- cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage medical device companies with innovative technologies, announced…
Read More
Gain Therapeutics Announces Closing of $10.1 Million Public Offering and Concurrent Private Placement of Common Stock and Warrants, Including Full Exercise of Over-Allotment Option
BETHESDA, Md., Nov. 24, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (“Gain” or the “Company”) (Nasdaq: GANX) today announced the closing of an underwritten…
Read More